Skip to Content
Uncategorized

Heads Up, Pontin Fans

There are some, right? Come on, a few? No? In any case, I shall be doing my weekly gig on CNN’s Headline News at 1.15 PM, EST. My subject? NitroMed’s new drug BiDil, which shows remarkable efficacy in treating congestive…
June 15, 2005

There are some, right? Come on, a few? No? In any case, I shall be doing my weekly gig on CNN’s Headline News at 1.15 PM, EST. My subject? NitroMed’s new drug BiDil, which shows remarkable efficacy in treating congestive heart failure in African Americans. NitroMed wants to specifically market the drug to blacks. But the whole idea has race activists understandably worried, and scientists who know something about drugs and genetic populations believe that race is far too vague and inaccurate a category to be useful in drug discovery. In the case of BiDil, as Technology Review’s executive editor David Rotman explained back in Race and Medicine in April, it is much more likely that BiDil would benefit any patient suffering from congestive heart failure as the result of hypertension. Which happens to be the most common reason African Americans have heart disease.

Keep Reading

Most Popular

Europe's AI Act concept
Europe's AI Act concept

A quick guide to the most important AI law you’ve never heard of

The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.

Uber Autonomous Vehicles parked in a lot
Uber Autonomous Vehicles parked in a lot

It will soon be easy for self-driving cars to hide in plain sight. We shouldn’t let them.

If they ever hit our roads for real, other drivers need to know exactly what they are.

supermassive black hole at center of Milky Way
supermassive black hole at center of Milky Way

This is the first image of the black hole at the center of our galaxy

The stunning image was made possible by linking eight existing radio observatories across the globe.

transplant surgery
transplant surgery

The gene-edited pig heart given to a dying patient was infected with a pig virus

The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.